Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2015-09-15 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
第五届董事会第一次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the first meeting of the fifth board of directors of 嘉事堂药业股份有限公司, including election of the chairman, appointment of committee members, and hiring of senior management personnel. It contains detailed voting results and biographies of the newly appointed directors and senior executives. The content focuses on changes in the company's board and senior management, which aligns with the category for announcements of changes in the company's board of directors or senior management. There is no financial data, earnings information, or report publication mentioned. The document is not a full annual report, audit report, or earnings release. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (5061 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2015-09-15 Chinese
2015年第二次股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2015 second extraordinary shareholders' meeting of 嘉事堂药业股份有限公司. It details the convening, attendance, voting procedures, and results of the shareholders' meeting, including election of directors and amendments to the company charter. The document is not a financial report, earnings release, or management discussion, but a legal opinion on the validity and compliance of the shareholders' meeting and its resolutions. This type of document is best classified under Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports official voting results and related legal opinions on a shareholders' meeting.
2015-09-15 Chinese
2015年半年度报告（更新后）
Interim / Quarterly Report Classification · 100% confidence The document is titled "嘉事堂药业股份有限公司 2015 年半年度报告全文" which translates to "Cachet Pharmaceutical Co., Ltd. 2015 Semi-Annual Report Full Text." It contains detailed financial data, including revenue, profit, cash flow, segment analysis, and management discussion for the first half of 2015 (January 1 to June 30, 2015). The document includes comprehensive financial statements and analysis for a period shorter than a full fiscal year, which matches the definition of an Interim / Quarterly Report (IR). The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the report itself, not just an announcement or summary. Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2015
2015-08-27 Chinese
2015年半年度报告摘要（更新后）
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2015 半年度报告摘要' which translates to '2015 Semi-Annual Report Summary'. It contains detailed financial data for the half-year period, including revenue, net profit, earnings per share, and asset information. It also includes shareholder information and management discussion and analysis of business segments. The document explicitly states it is a summary of the half-year report and references the full report available elsewhere. The length is 4293 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR) as it is a comprehensive financial report for a period shorter than a full fiscal year with actual financial statements and analysis. H1 2015
2015-08-27 Chinese
2015年半年度报告的补充更正公告
Report Publication Announcement Classification · 95% confidence The document is titled as a "2015 年半年度报告的补充更正公告" which translates to "2015 Semi-Annual Report Supplementary Correction Announcement." It states that the company previously published the 2015 semi-annual report and is now issuing a correction to a section of the Board of Directors' report, specifically the "core competitiveness analysis." The document provides corrected content and apologizes for any inconvenience caused. The document length is 3185 characters, which is relatively short and mainly serves to correct and supplement a previously issued semi-annual report rather than presenting the full financial statements or substantive financial data itself. It also directs readers to the full corrected report on the official disclosure website. Therefore, this document is an announcement related to the publication or correction of a report, not the full interim report itself. According to the "Menu vs Meal" rule, such a document should be classified as a Report Publication Announcement (RPA) rather than an Interim/Quarterly Report (IR).
2015-08-27 Chinese
关于签订合作协议的公告
Capital/Financing Update Classification · 90% confidence The document is a public announcement by 嘉事堂药业股份有限公司 regarding the signing of cooperation agreements with China Life Insurance and local governments. It details the purpose, main content, and impact of these agreements related to medical insurance cost control and pharmaceutical logistics. There are no financial statements, earnings data, or regulatory certifications. The document is an announcement of a business cooperation agreement, not a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified under Capital/Financing Update (CAP) as it relates to business cooperation agreements that may impact company financing or capital structure indirectly, but more precisely it is a business cooperation announcement which is closest to CAP among the given options. Confidence is high due to clear content and document length (1703 characters) indicating a short announcement rather than a full report.
2015-08-25 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.